Xi Huang
- Hematology top 10%
- Multiple Myeloma Research and Treatments 10
-
- Cytokine Signaling Pathways and Interactions 4
- Pancreatic and Hepatic Oncology Research 3
-
- Immune cells in cancer 4
-
- Protein Degradation and Inhibitors 8
- Ubiquitin and proteasome pathways 6
- Histone Deacetylase Inhibitors Research 4
-
- Air Quality and Health Impacts 3
- Cited by
- HematologyOncologyCancer Research
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (2 papers)Blood (5 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Xi Huang
42 papers receiving 703 citations
Peers
Comparison fields: 5 of 97
- Hematology 102
- Oncology 199
- Cancer Research 107
- Immunology 139
- Molecular Biology 340
Countries citing papers authored by Xi Huang
This map shows the geographic impact of Xi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Huang more than expected).
Fields of papers citing papers by Xi Huang
This network shows the impact of papers produced by Xi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Huang. The network helps show where Xi Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xi Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 16 | |
| 9 | 2020 | 35 | |
| 10 | 2019 | 41 | |
| 11 | 2019 | 77 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 42 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 21 | |
| 16 | 2018 | 15 | |
| 17 | 2016 | 29 | |
| 18 | 2003 | 12 | |
| 19 | 1995 | 31 | |
| 20 | 1994 | 60 |
About Xi Huang
Xi Huang is a scholar working on Hematology, Biological Psychiatry and Structural Biology, having authored 45 papers that have together received 711 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (6 papers), Histone Deacetylase Inhibitors Research (4 papers), Immune cells in cancer (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Air Quality and Health Impacts (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Hematology (102 citations), Oncology (199 citations) and Cancer Research (107 citations). Xi Huang has collaborated with scholars based in China, United States and France. Frequent co-authors include Enfan Zhang, Jingsong He, Zhen Cai, Haimeng Yan, Qingxiao Chen, Qing Yang, Jinlong Jian, Qing Yi, Li Yang and Wen Cao. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.